(Q40126108)

17 September 2017

European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. (English)

1 reference

17 September 2017

prevention of HIV/AIDS

0 references

author

Giovanni Guaraldi

5

1 reference

17 September 2017

6

C Katlama

1 reference

17 September 2017

1

J D Lundgren

1 reference

17 September 2017

10

P Reiss

1 reference

17 September 2017

M Battegay

2

1 reference

17 September 2017

G Behrens

3

1 reference

17 September 2017

S De Wit

4

1 reference

17 September 2017

E Martinez

7

1 reference

17 September 2017

D Nair

8

1 reference

17 September 2017

W G Powderly

9

1 reference

17 September 2017

J Sutinen

11

1 reference

17 September 2017

A Vigano

12

1 reference

17 September 2017

EACS Executive Committee

13

1 reference

17 September 2017

1 February 2008

1 reference

17 September 2017

1 reference

17 September 2017

9

1 reference

17 September 2017

2

1 reference

17 September 2017

72-81

1 reference

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

17 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

A cure for cardiovascular disease? Combination treatment has enormous potential, especially in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Antiretroviral-therapy-associated lipoatrophy: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Practice Guidelines For Primary Care Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2007.00534.X

10.1111/J.1468-1293.2007.00534.X

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference